<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We present 2 children with severe syndromal <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> who were in need of urgent midface advancement surgery due to recurrent ocular <z:hpo ids='HP_0001373'>dislocations</z:hpo> (Pfeiffer's syndrome type II) or severe upper <z:e sem="disease" ids="C0001883,C0853236" disease_type="Disease or Syndrome" abbrv="">respiratory obstruction</z:e> (<z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon's syndrome</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>They were operated using distraction osteogenesis, with gradual midface or monobloc advancements </plain></SENT>
<SENT sid="2" pm="."><plain>In the Pfeiffer patient, a maxillary distraction of 25 mm achieved effective cessation of ocular <z:hpo ids='HP_0001373'>dislocations</z:hpo>, whereas a 23-mm monobloc advancement in the <z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon</z:e> patient achieved cessation of nocturnal arterial desaturations </plain></SENT>
<SENT sid="3" pm="."><plain>No major postoperative complications were recorded </plain></SENT>
<SENT sid="4" pm="."><plain>Distraction osteogenesis has become a versatile and safe technique that allows for large skeletal advancements </plain></SENT>
</text></document>